Quantum Biosystems Inc., an Osaka-based company developing a faster genome sequencer, raised 2.4 billion yen ($20.5 million) in venture-capital funding from firms including Jafco Co., people with knowledge of the matter said.
The investors also include state-backed Innovation Network Corp. of Japan, Mizuho Capital Co., University of Tokyo Edge Capital Co. and Mitsubishi UFJ Capital Co., the people said, asking not to be identified before a public announcement.
